Intermittent versus daily therapy for treating tuberculosis in children
Evidence from four randomised trials was insufficient to determine that the use of daily drug treatment was more effective than intermittent (twice- or thrice-weekly) treatment for children with tuberculosis.
Childhood tuberculosis is a neglected global public health problem. Rifampicin-containing drugs given daily for six months cure over 90% of infected children, but poor adherence and supervision reduces treatment success. The aim of the review was to establish if daily anti-tuberculosis treatments were better than intermittent treatments.
We’ve already reached tens of thousands of people with plain language summaries of systematic reviews. If you’d like to help us to continue our work, please consider a donation.
Donate with PayPal
You can also donate through the Charities Aid Foundation (CAF) here. If you are based in the USA and want to make a tax-deductable donation, please donate to Evidence Aid via the British Schools and Universities Foundation.